Researchers at Integra Therapeutics, in collaboration with the Pompeu Fabra University (UPF) Department of Medicine and Life ...

Uganda's flagship pharmaceutical and biotechnology giant, Dei BioPharma, has dismissed as false and malicious reports alleging a mass exodus of its senior scientists from the company's ...

The company has received a “limited number” of non-binding proposals, mostly from groups of financial investors, for a ...

A survey of biotech investors found that 86% believe that fewer than half of management teams communicate effectively, ...

Internet company The9 said Thursday its Singapore investee firm is expected to gain a Nasdaq listing and will have a roughly $1.5 billion pre-transaction equity value.

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and ne ...

Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the fourth quarter: Agios ...

September yields at least 23 listing applications from mainland biotech firms eyeing the city’s lucrative fundraising market.

The government on Wednesday approved phase three of the biomedical research career programme aimed at training over 2,000 ...

Researchers at Integra Therapeutics , in collaboration with the Pompeu Fabra University (UPF) Department of Medicine and Life Sciences ( MELIS ) and ...

Second-quarter sales of Enbrel, an arthritis treatment that first earned approval in 1998, declined by 34% year over year to ...

Addressing Critical Unmet Medical Need ExQor Technologies, a Boston MA based biotechnology company, is preparing for clinical trials for its proprietary brain regenerative medicine platform targeting ...